Trial Profile
Risk of Hemorrhage in Patients Prescribed Arixtra Compared to LMWH.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary) ; Dalteparin sodium; Enoxaparin sodium; Nadroparin calcium; Tinzaparin sodium
- Indications Thrombosis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 10 Feb 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 10 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2010 New trial record